Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 14:11:746917.
doi: 10.3389/fonc.2021.746917. eCollection 2021.

Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment

Affiliations
Review

Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment

Fengqian Chen et al. Front Oncol. .

Abstract

As the main cause of death in the world, cancer is one of the major health threats for humans. In recent years, traditional Chinese medicine has gained great attention in oncology due to the features of multi-targets, multi-pathways, and slight side effects. Moreover, lots of traditional Chinese medicine can exert immunomodulatory effects in vivo. In the tumor microenvironment, tumor cells, immune cells as well as other stromal cells often coexist. With the development of cancer, tumor cells proliferate uncontrollably, metastasize aggressively, and modulate the proportion and status of immune cells to debilitate the antitumor immunity. Reversal of immunosuppressive tumor microenvironment plays an essential role in cancer prevention and therapy. Immunotherapy has become the most promising strategy for cancer therapy. Chinese medicine compounds can stimulate the activation and function of immune cells, such as promoting the maturation of dendritic cells and inducing the differentiation of myeloid-derived suppressor cells to dendritic cells and macrophages. In the present review, we summarize and discuss the effects of Chinese medicine compounds on immune cells in the tumor microenvironment, including innate immune cells (dendritic cells, natural killer cells, macrophages, and myeloid-derived suppressor cells) and adaptive immune cells (CD4+/CD8+ T lymphocytes and regulatory T cells), and the various immunomodulatory roles of Chinese medicine compounds in cancer therapy such as improving tumor-derived inflammation, enhancing the immunity after surgery or chemotherapy, blocking the immune checkpoints, et al., aiming to provide more thoughts for the anti-tumor mechanisms and applications of Chinese medicine compounds in terms of tumor immunity.

Keywords: Chinese medicine compounds; antitumor immunity; cancer; immune cell; microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The regulatory effects of Chinese medicine compounds in immune cells. Chinese medicine compounds: 1. Modified Si-Jun-Zi Decoction; 2. Haimufang decoction; 3. Compound kushen injection; 4. Yu-ping-feng; 5. XIAOPI formula; 6. Dahuang Zhechong Pills; 7. Jianpi Yangzheng; 8. Yangyin Wenyang; 9. Jinfukang; 10. Tien-Hsien liquid; 11. ACNO; 12. Yanghe Decoction; 13. Jianpi Huayu Decoction; 14. Baoyuan Jiedu decoction; 15. Ze-Qi-Tang; 16. Shuangshen granules; 17. Quxie capsule; 18. Compound Sophorae Decoction; 19. JC-001 20. Shugan Jianpi formula; 21. Xiao-Ai-Ping; 22. Shenqi Fuzheng Injection; 23. Feiyanning Decoction; 24. Yi-Yi-Fu-Zi-Bai-Jiang-San; 25. Xihuang Pill; 26. Fuzheng Fangai.
Figure 2
Figure 2
The immunoregulatory patterns of Chinese medicine compounds in cancer therapy. Chinese medicine compounds: (A) Banxia Xiexin decoction; (B) Compound kushen injection; (C) NHE-06; (D) Ruyiping+Platycodon grandiflorum; (E) Kejinyan decoction; (F) DahuangZhechong Pills; (G) San Huang decoction; (H) PHY906; (I) Ciji-Hua’ai-Baosheng; (J) Gegen Qinlian decoction; (K) Yangyin Fuzheng Decoction; (L) Bu Fei Decoction; (M) Huoxue Yiqi Recipe-2; (N) Bu-zhong-yi-qi decoction; (O) Modified Jian-pi-yang-zheng decoction; (P) Danggui Buxue decoction; (Q) XH formula; (R) Shugan Liangxue decoction.

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin (2021) 71(3):209–49. doi: 10.3322/caac.21660 - DOI - PubMed
    1. Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR. Targeting Tumor Microenvironment for Cancer Therapy. Int J Mol Sci (2019) 20(4):840. doi: 10.3390/ijms20040840 - DOI - PMC - PubMed
    1. Fan Y, Ma Z, Zhao L, Wang W, Gao M, Jia X, et al. . Anti-Tumor Activities and Mechanisms of Traditional Chinese Medicines Formulas: A Review. BioMed Pharmacother (2020) 132:110820. doi: 10.1016/j.biopha.2020.110820 - DOI - PubMed
    1. Dedong C, Huilin X, Anbing H, Ximing X, Wei G. The Effect of ShenQi FuZheng Injection in Combination With Chemotherapy Versus Chemotherapy Alone on the Improvement of Efficacy and Immune Function in Patients With Advanced Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS One (2016) 11(3):e0152270. doi: 10.1371/journal.pone.0152270 - DOI - PMC - PubMed
    1. Cao ZY, Chen XZ, Liao LM, Peng J, Hu HX, Liu ZZ, et al. . Fuzheng Yiliu Granule Inhibits the Growth of Hepatocellular Cancer by Regulating Immune Function and Inducing Apoptosis In Vivo and In Vitro . Chin J Integr Med (2011) 17(9):691–7. doi: 10.1007/s11655-011-0847-3 - DOI - PubMed